Trial · NCT03629418
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of acute kidney injury (AKI) within 7 days after surgery | Up to 7 days after surgery | Development of AKI within 7 days after surgery is diagnosed according to the Kidney Disease Improving Global Outcomes (KDIGO) criteria |
| Secondary | Classification of AKI within 7 days after surgery | Up to 7 days after surgery | Development of AKI within 7 days after surgery is diagnosed according to the KDIGO criteria |
| Secondary | Incidence of delirium within 7 days after surgery | Up to 7 days after surgery | Development of delirium within 7 days after surgery is assessed with the Confusion Assessment Method (3D-CAM for patients without mechanical ventilation and CAM-ICU for patients with mechanical ventilation). |
| Secondary | Duration of mechanical ventilation after surgery | Up to 30 days after surgery | Duration of mechanical ventilation after surgery |
| Secondary | Length of stay in intensive care unit (ICU) after surgery | Up to 30 days after surgery | Length of stay in intensive care unit (ICU) after surgery |
| Secondary | Length of stay in hospital after surgery | Up to 30 days after surgery | Length of stay in hospital after surgery |
| Secondary | Incidence of major adverse cardiovascular events (MACEs) within 30 days after surgery | Up to 30 days after surgery | MACEs within 30 days after surgery include cardiovascular death, non-fatal cardiac arrest, acute myocardial infarction, revascularization, and stroke. |
| Secondary | Incidence of non-MACE complications within 30 days after surgery | Up to 30 days after surgery | Non-MACE complications within 30 days after surgery indicate new-onset medical conditions other than MACEs that produce harmful effects on patients' recovery and required therapeutic intervention. |
| Secondary | All-cause 30-day mortality | At 30 days after surgery | All-cause 30-day mortality |
| Secondary | 2-year overall survival after surgery | Up to 2 years after surgery | 2-year overall survival after surgery |
| Secondary | 2-year major adverse cardiovascular event (MACE)-free survival after surgery | Up to 2 years after surgery | MACEs within 2 years after surgery include cardiovascular death, non-fatal cardiac arrest, acute myocardial infarction, revascularization, and stroke. |
| Secondary | Cognitive function in 1- and 2-year survivors | At the end of the 1st and 2nd years after surgery | Cognitive function in 1- and 2-year survivors is assessed with the modified Telephone Interview for Cognitive Status (TICS-m, score ranges from 0 to 40, with higher score indicating better function). |
| Secondary | Quality of life in 1- and 2- year survivors: SF-36 | At the end of the 1st and 2nd years after surgery | Quality of life in 1- and 2-year survivors is assessed with the 36-Item Short Form Health Survey (SF-36). The SF-36 evaluates 8 different domains of quality of life, i.e., physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health. The score of each domain ranges from 0 to 100, with high score indicating better function. |
| Other | Pain severity within 3 days after surgery: NRS | Up to 3 days after surgery | Pain severity is assessed with the Numeric Rating Scale (NRS, an 11-point scale where 0=no pain and 10=the worst pain) twice daily (8:00-10:00 am, 18:00-20:00 pm) after surgery. |
| Other | Daily prevalence of delirium during postoperative days 1-7 | During the first 7 days after surgery | Daily prevalence of delirium during postoperative days 1-7 |
| Other | Duration of intraoperative cerebral desaturation (sub-study) | During surgery | Duration of cerebral desaturation is monitored by near-infrared spectroscopy. Cerebral desaturation is defined as a decrease of more than 10% from baseline. Performed in part of enrolled patients. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03629418/registered